Selected Publications (Corresponding Author)

번호	제목	첨부
19	Kang SM, Jung D, Noh S, Shin S, Kim M, Cho H, Lee B, Yea K, Baek MC. Surface-Engineered Natural Killer Cell-Derived Small Extracellular Vesicles Induce Potent Anti-Tumour Effects in Lung Cancer Cells. J Extracell Biol . 2025 Aug
18	Jeong J, Park JK, Shin J, Jung I, Kim HW, Park A, Cho H, Kang SM, Shin S, Park E, Kim J, Noh S, Ahn Y, Kim DK, Lee JY, Seo D, Baek MC, Yea K.Inflammatory cytokine-primed MSC-derived extracellular vesicles ameliorate acute lung injury via enhanced immunomodulation and alveolar repair. Stem Cell Res Ther. 2025 Aug (IF: 7.3)
17	Cho H, Ju H, Shin S, Ahn Y, Park E, Jung I, Kang SM, Noh S, Shin J, Park JK, Jeong J, Seo D, Song BJ, Yea K, Baek MC T cell-derived extracellular vesicles with anti-transferrin receptor antibody for multi-cancer targeting. Nano Letters. 2025 June (IF: 9.1)
16	Cho H, Ju H, Ahn Y, Jang J, Cho J, Park E, Kang SM, Lee J, Seo D, Baek MC* and Yea K*.Engineered extracellular vesicles with surface FGF21 and enclosed miR-223 for treating metabolic dysfunction-associated steatohepatitis. Biomaterials. 2025 Apr (IF: 12.8)
15	Jang J, Shin J, Ahn Y, Kim K, Cho J, Lee WJ, Nam C, Baek MC, Seo D and Yea K*. Modular and Nondisturbing Chimeric Adaptor Protein for Surface Chemistry of Small Extracellular Vesicles. ACS Nano. 2025. Mar (IF: 15.8)
14	Noh S, Ryu S, Jung D, Shin S, Jung I, Kang SM, Choi SJ, Cho H, Kim KS, Schwammle M, Jeong Y, Bucher F, Im S, Yea K* and Baek MC*.IL2-Mediated Modulation of sEV secretion and PD-L1 expression: A Novel Perspective for Neutralizing Immune Suppression within Cancer Cells. Cancer Communications. 2024 Oct (IF: 20.1)
13	Jung I, Shin S, Baek MC* and Yea K*. Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications. Exp Mol Med. 2024 Jan 4 (Review, IF: 12.8)
12	Cho H, Jung I, Ju H, Yea K. and Baek MC. Engineered CD8+ T cell-derived extracellular vesicles induce enhanced anti-cancer efficacy and targeting to lung cancer cells. Cytokine. 2023 Sep (IF: 3.926)
11	Shin J, Kim MJ, Quan3 X, Kim JW, Lee S, Park S* , Jeong JY* and Yea K*.Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia. BMC Cacer. 2023 May 31 (IF: 4.638)
10	Noh S, Park JK, Shin S, Jeong J, Jung I, Shin J, Park E, Yea K. Exploring Membrane-tethering Technology for Proteins as a Versatile Tool for Uncovering Novel Disease Targets and Advancing Biotherapeutic Development. Israel Journal of Chemistry. 2023 April 22th (Review, IF: 3.357)